Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

Clinical trial NCT00473746 · COMPLETED

Trial details

NCT number: NCT00473746
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Neoplasms

Start date: 2006-06-01
Primary completion: 2012-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.